Xilio Therapeutics (XLO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Xilio Therapeutics released FY2025 9 Months Earnings on November 13 (EST), with actual revenue of USD 30.08 M and EPS of USD -0.7975

04:00

Xilio Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 19.07 M (forecast USD 18.64 M), actual EPS USD -0.3142 (forecast USD -0.03)

04:00

Nov7

Xilio Therapeutics Presents Phase 1 Data on Tumor-Activated IL-12 Drug

14:01

Aug15

Xilio Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 11.01 M, actual EPS USD -0.3399

03:00

Xilio Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 8.084 M (forecast USD 7.4 M), actual EPS USD -0.3057 (forecast USD -0.1)

03:00

Jun18

Rene Russo Purchases Xilio Therapeutics Inc. Shares

20:57